Nathan J Dowden - Net Worth and Insider Trading

Nathan J Dowden Net Worth

The estimated net worth of Nathan J Dowden is at least $1 Million dollars as of 2025-05-05. Nathan J Dowden is the President & COO of Entrada Therapeutics Inc and owns about 125,149 shares of Entrada Therapeutics Inc (TRDA) stock worth over $1 Million. Details can be seen in Nathan J Dowden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nathan J Dowden has not made any transactions after 2024-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Nathan J Dowden

To

Nathan J Dowden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nathan J Dowden owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .

Click here to see the complete history of Nathan J Dowden’s form 4 insider trades.

Insider Ownership Summary of Nathan J Dowden

Ticker Company Transaction Date Type of Owner
TRDA Entrada Therapeutics Inc 2024-09-26 Chief Operating Officer

Nathan J Dowden Latest Holdings Summary

Nathan J Dowden currently owns a total of 1 stock. Nathan J Dowden owns 125,149 shares of Entrada Therapeutics Inc (TRDA) as of September 26, 2024, with a value of $1 Million.

Latest Holdings of Nathan J Dowden

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRDA Entrada Therapeutics Inc 2024-09-26 125,149 9.23 1,155,125

Holding Weightings of Nathan J Dowden


Nathan J Dowden Form 4 Trading Tracker

According to the SEC Form 4 filings, Nathan J Dowden has made a total of 15 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 847 shares on September 26, 2024, which brought Nathan J Dowden around $13,552.

Insider Trading History of Nathan J Dowden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nathan J Dowden Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nathan J Dowden Ownership Network

Ownership Network List of Nathan J Dowden

No Data

Ownership Network Relation of Nathan J Dowden

Insider Network Chart

Nathan J Dowden's Executive Compensation Overview

Company Year Salary($) Bonus($) Stock Awards($) Option Awards($) Equity Awards($) Non-Equity Incentive Plan($) All Other Compensation($) Change in Pension and Deferred Comp($) Total($)
Entrada Therapeutics Inc 2023 456,501 N/A 392,772 398,384 N/A 224,598 13,200 N/A 1,485,455
LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT

Nathan J Dowden Owned Company Details

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Nathan J Dowden is the Chief Operating Officer of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Financial Officer Kory James Wentworth , 10 percent owner Mpm Bioventures 2018, L.p. , and 10 percent owner Mpm Bioventures 2014, L.p. .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Nathan J Dowden made 4 insider transaction in Entrada Therapeutics Inc (TRDA) with a net sale of 32,073. Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 62,279 shares made by Natarajan Sethuraman , a net sale of 37,960 shares made by Kory James Wentworth , and a net sale of 9,900 shares made by Dipal Doshi .

In summary, during the past 3 months, insiders sold 1,784 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 1,784 shares. During the past 18 months, 231,656 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 186,288 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entrada Therapeutics Inc Insider Transactions

No Available Data

Nathan J Dowden Mailing Address

Above is the net worth, insider trading, and ownership report for Nathan J Dowden. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nathan J Dowden's mailing address is: Boston Ma 02210.